Indoco Remedies Beheer
Beheer criteriumcontroles 3/4
De CEO Indoco Remedies is Sundeep Bambolkar, benoemd in Feb2012, heeft een ambtstermijn van 12.75 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 75.54M, bestaande uit 61.7% salaris en 38.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.18% van de aandelen van het bedrijf, ter waarde ₹ 54.03M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.9 jaar en 14 jaar.
Belangrijke informatie
Sundeep Bambolkar
Algemeen directeur
₹75.5m
Totale compensatie
| Percentage CEO-salaris | 61.7% |
| Dienstverband CEO | 12.8yrs |
| Eigendom CEO | 0.2% |
| Management gemiddelde ambtstermijn | 7.9yrs |
| Gemiddelde ambtstermijn bestuur | 14yrs |
Recente managementupdates
Recent updates
Indoco Remedies Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Oct 27
Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders
May 24Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts
Jan 26Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?
Jan 26We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now
Sep 16Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly
May 21Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50
Aug 31Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50
Jul 04Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?
Jul 02Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly
Jun 10Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?
Mar 25Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price
Mar 09What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?
Feb 22Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?
Feb 07Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 17Is Indoco Remedies (NSE:INDOCO) A Risky Investment?
Dec 27
Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)
Dec 06What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?
Nov 14Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹321m |
| Jun 30 2024 | n/a | n/a | ₹767m |
| Mar 31 2024 | ₹76m | ₹47m | ₹985m |
| Dec 31 2023 | n/a | n/a | ₹1b |
| Sep 30 2023 | n/a | n/a | ₹1b |
| Jun 30 2023 | n/a | n/a | ₹1b |
| Mar 31 2023 | ₹65m | ₹40m | ₹1b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹2b |
| Jun 30 2022 | n/a | n/a | ₹2b |
| Mar 31 2022 | ₹46m | ₹30m | ₹2b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹28m | ₹20m | ₹930m |
| Dec 31 2020 | n/a | n/a | ₹734m |
| Sep 30 2020 | n/a | n/a | ₹571m |
| Jun 30 2020 | n/a | n/a | ₹393m |
| Mar 31 2020 | ₹18m | ₹15m | ₹241m |
| Dec 31 2019 | n/a | n/a | ₹302m |
| Sep 30 2019 | n/a | n/a | ₹264m |
| Jun 30 2019 | n/a | n/a | ₹111m |
| Mar 31 2019 | ₹15m | ₹12m | -₹29m |
| Mar 31 2018 | ₹16m | ₹12m | ₹412m |
Compensatie versus markt: De totale vergoeding ($USD 894.62K ) Sundeep } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 271.27K ).
Compensatie versus inkomsten: De vergoeding van Sundeep is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Sundeep Bambolkar (64 yo)
12.8yrs
Tenure
₹75,540,000
Compensatie
Mr. Sundeep Vasant Bambolkar has been a Joint Managing Director at Indoco Remedies Limited since February 15, 2012. Mr. Bambolkar served as Chief Financial Officer at Indoco Remedies Limited from March 23,...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Non-Executive Chairman & Whole time Director | 61.3yrs | ₹36.89m | 4.7% ₹ 1.4b | |
| Joint MD & Executive Director | 12.8yrs | ₹75.54m | 0.18% ₹ 54.0m | |
| MD & Executive Director | 12.8yrs | ₹85.42m | 6.12% ₹ 1.8b | |
| Chief Financial Officer | 3yrs | ₹17.38m | geen gegevens | |
| GM of Legal | 1.9yrs | ₹5.48m | geen gegevens | |
| Chief Technical Officer | no data | ₹7.57m | geen gegevens | |
| President of Sales & Marketing | no data | geen gegevens | geen gegevens | |
| Chief Marketing Officer | no data | geen gegevens | geen gegevens | |
| Vice President of Corporate HR | no data | geen gegevens | geen gegevens | |
| Head of OSD | no data | geen gegevens | geen gegevens | |
| Executive Vice President of International Business for Regulated Markets | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Sales for API | no data | geen gegevens | geen gegevens |
7.9yrs
Gemiddelde duur
60.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van INDOCO is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.9 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Non-Executive Chairman & Whole time Director | 61.3yrs | ₹36.89m | 4.7% ₹ 1.4b | |
| Joint MD & Executive Director | 20.7yrs | ₹75.54m | 0.18% ₹ 54.0m | |
| MD & Executive Director | 20.7yrs | ₹85.42m | 6.12% ₹ 1.8b | |
| Independent Non-Executive Director | 19.6yrs | ₹580.00k | geen gegevens | |
| Independent Non-Executive Director | 17.6yrs | ₹660.00k | 0.013% ₹ 3.8m | |
| Non-Executive Director | 10.5yrs | ₹360.00k | geen gegevens | |
| Non-Executive & Independent Director | 4.7yrs | ₹500.00k | geen gegevens | |
| Independent Non-Executive Director | 4.1yrs | ₹460.00k | 0.0054% ₹ 1.6m | |
| Independent Director | less than a year | geen gegevens | geen gegevens | |
| Independent Director | less than a year | geen gegevens | geen gegevens |
14.0yrs
Gemiddelde duur
67yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van INDOCO zijn ervaren en ervaren (gemiddelde ambtstermijn van 14 jaar).